(Q50438486)

14 March 2018

title

Simultaneous integrated boost intensity-modulated radiotherapy (SIB‑IMRT) in nasopharyngeal cancer. (English)

1 reference

14 March 2018

adaptive radiation therapy

main subject

0 references

author name string

Evangelia Peponi

1

1 reference

14 March 2018

Christoph Glanzmann

2

1 reference

14 March 2018

Guntram Kunz

3

1 reference

14 March 2018

Christoph Renner

4

1 reference

14 March 2018

Katja Tomuschat

5

1 reference

14 March 2018

Gabriela Studer

6

1 reference

14 March 2018

publication date

22 February 2010

1 reference

14 March 2018

Strahlentherapie und Onkologie

published in

1 reference

14 March 2018

volume

186

1 reference

14 March 2018

issue

3

1 reference

14 March 2018

page(s)

135-142

1 reference

14 March 2018

https://scigraph.springernature.com/pub.10.1007/s00066-010-2048-y

exact match

0 references

cites work

The impact of race on survival in nasopharyngeal carcinoma: a matched analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Applications of two-step intensity modulated arc therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Descriptive epidemiology and survival analysis of nasopharyngeal carcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

The role of brachytherapy in early-stage nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Prognostic factors and significance of the revised 6th edition of the AJCC classification in patients with locally advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Monitoring of Tumor Oxygenation Changes in Head-and-Neck Carcinoma Patients Breathing a Hyperoxic Hypercapnic Gas Mixture with a Noninvasive MRI Technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Inverse treatment planning and stereotactic intensity-modulated radiation therapy (IMRT) of the tumor and lymph node levels for nasopharyngeal carcinomas. Description of treatment technique, plan comparison, and case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Further improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

IMRT with compensators for head-and-neck cancers treatment technique, dosimetric accuracy, and practical experiences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

ConPas: a 3-D conformal parotid gland-sparing irradiation technique for bilateral neck treatment as an alternative to IMRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Epidemiology of nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2048-Y

Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer

21 January 2018

1 reference

12 December 2020

Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma

1 reference

12 December 2020

The local-regionally advanced nasopharyngeal carcinoma jigsaw puzzle: where does the chemotherapy piece fit?

1 reference

12 December 2020

Carcinoma of the nasopharynx. Eighteen years' experience with megavoltage radiation therapy

1 reference

12 December 2020

A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma

1 reference

12 December 2020

Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost

1 reference

12 December 2020

Prognostic significance of keratinization in nasopharyngeal carcinoma

1 reference

12 December 2020

Megavoltage irradiation of epithelial tumors of the nasopharynx

1 reference

12 December 2020

Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site

1 reference

12 December 2020

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

12 December 2020

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

12 December 2020

Locoregional failure analysis in head-and-neck cancer patients treated with IMRT

1 reference

12 December 2020

10.1007/S00066-010-2048-Y

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018